Evelo Biosciences, Inc.
Index- P/E- EPS (ttm)-2.31 Insider Own0.20% Shs Outstand53.53M Perf Week-10.63%
Market Cap112.46M Forward P/E- EPS next Y-1.45 Insider Trans0.00% Shs Float50.49M Perf Month-19.57%
Income-122.20M PEG- EPS next Q-0.55 Inst Own94.20% Short Float16.61% Perf Quarter-53.75%
Sales- P/S- EPS this Y2.70% Inst Trans0.07% Short Ratio26.92 Perf Half Y-82.48%
Book/sh0.16 P/B11.56 EPS next Y4.60% ROA-97.60% Target Price17.75 Perf Year-83.35%
Cash/sh1.13 P/C1.64 EPS next 5Y- ROE-255.80% 52W Range1.60 - 17.12 Perf YTD-69.52%
Dividend- P/FCF- EPS past 5Y-37.50% ROI- 52W High-89.02% Beta1.82
Dividend %- Quick Ratio4.10 Sales past 5Y- Gross Margin- 52W Low17.87% ATR0.30
Employees122 Current Ratio4.10 Sales Q/Q- Oper. Margin- RSI (14)37.67 Volatility17.33% 14.45%
OptionableYes Debt/Eq0.00 EPS Q/Q13.80% Profit Margin- Rel Volume1.10 Prev Close1.85
ShortableYes LT Debt/Eq5.36 EarningsMar 24 BMO Payout- Avg Volume311.59K Price1.88
Recom2.00 SMA20-17.41% SMA50-33.12% SMA200-70.01% Volume42,028 Change1.62%
Nov-01-21Upgrade Chardan Capital Markets Neutral → Buy $12
Jun-23-21Initiated Cantor Fitzgerald Overweight $28
Apr-12-21Upgrade Jefferies Hold → Buy $11 → $18
Dec-23-20Initiated JMP Securities Mkt Outperform $27
May-21-20Downgrade Morgan Stanley Overweight → Equal-Weight $8
May-12-20Downgrade Jefferies Buy → Hold $18 → $6
Apr-30-19Initiated Jefferies Buy $18
Jan-29-19Initiated Chardan Capital Markets Neutral $10
May-12-22 10:47AM  
Apr-21-22 06:00AM  
Apr-14-22 11:22AM  
Apr-06-22 06:00AM  
Mar-26-22 12:00PM  
Mar-24-22 01:30PM  
Mar-17-22 07:00AM  
Mar-07-22 06:00AM  
Mar-02-22 08:50AM  
Feb-28-22 09:00AM  
Feb-24-22 07:55AM  
Feb-17-22 07:00AM  
Feb-15-22 10:05AM  
Feb-11-22 12:00PM  
Feb-07-22 07:00AM  
Jan-17-22 07:00AM  
Jan-04-22 07:00AM  
Dec-14-21 07:00AM  
Nov-09-21 07:00AM  
Oct-28-21 07:01PM  
Oct-21-21 07:00AM  
Oct-18-21 08:49AM  
Oct-13-21 10:47AM  
Sep-29-21 03:37AM  
Sep-28-21 12:38PM  
Sep-27-21 12:11PM  
Sep-20-21 07:00AM  
Sep-09-21 07:00AM  
Sep-08-21 08:30AM  
Sep-07-21 07:00AM  
Aug-06-21 08:46AM  
Jul-31-21 05:31AM  
Jul-29-21 07:00AM  
Jul-22-21 07:00AM  
Jul-14-21 04:01PM  
Jun-21-21 06:50PM  
Jun-16-21 04:01PM  
Jun-03-21 04:01PM  
Jun-01-21 07:00AM  
May-26-21 07:00AM  
May-25-21 06:00AM  
May-19-21 09:01AM  
May-13-21 07:00AM  
Apr-30-21 03:59PM  
Apr-29-21 03:01PM  
Apr-22-21 07:00AM  
Apr-20-21 04:01PM  
Apr-19-21 05:50AM  
Apr-15-21 07:00AM  
Apr-05-21 07:00AM  
Mar-30-21 09:30AM  
Mar-23-21 03:00AM  
Mar-09-21 05:00PM  
Mar-02-21 07:00AM  
Feb-16-21 07:00AM  
Jan-28-21 09:08PM  
Jan-21-21 08:05AM  
Jan-20-21 07:00AM  
Jan-07-21 07:00AM  
Dec-23-20 10:07AM  
Dec-21-20 07:00AM  
Dec-14-20 11:21PM  
Dec-09-20 09:00AM  
Dec-03-20 07:00AM  
Nov-27-20 10:47AM  
Nov-10-20 09:41AM  
Nov-09-20 08:00AM  
Oct-29-20 07:00AM  
Oct-22-20 04:01PM  
Oct-15-20 07:00AM  
Oct-14-20 07:00AM  
Oct-13-20 07:00AM  
Oct-12-20 09:00AM  
Sep-14-20 07:06AM  
Sep-08-20 07:00AM  
Jul-30-20 07:00AM  
Jul-23-20 07:00AM  
Jul-07-20 08:00AM  
Jul-01-20 07:08AM  
Jun-24-20 07:56PM  
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in clinical development trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also engages in developing EDP1867, an inactivated investigational oral biologic for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Epstein David RDirectorMay 02Option Exercise0.004,926066,957May 02 04:03 PM
Epstein David RDirectorMar 31Option Exercise0.004,926062,031Apr 01 04:05 PM
Epstein David RDirectorFeb 28Option Exercise0.004,926057,105Mar 01 04:07 PM
Epstein David RDirectorJan 31Option Exercise0.004,925052,179Jan 31 05:06 PM
Epstein David RDirectorDec 31Option Exercise0.004,926047,254Jan 03 04:23 PM
Epstein David RDirectorNov 30Option Exercise0.004,926042,328Dec 01 04:39 PM
Epstein David RDirectorNov 01Option Exercise0.004,925037,402Nov 01 05:22 PM
Epstein David RDirectorOct 01Option Exercise0.004,927032,477Oct 01 04:42 PM
Epstein David RDirectorSep 03Option Exercise0.009,850027,550Sep 03 04:55 PM